Results - Financial Results For The Quarter And Half Year Ended September 30, 2018.
Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held on 13th November, 2018 inter alia considered and approved the Un-audited Financial Results of the Company for the Quarter and Half Year ended September 30, 2018.... Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Further to our letter dated October 26, 2018, and pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the Notice of Postal Ballot being sent to members, seeking approval of the members through Postal Ballot (including voting by electronic means) for the following special businesses: 1. Alteration of Memorandum of Association of the Company;... Board Meeting Intimation for Pursuant To The Provisions Of Regulation 29 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, We Wish To Inform You That A Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Tuesday, November 13, 2018, Inter Alia, To Consider And Approve The Un-Audited Financial Results Of The Company For The Quarter Ended September 30, 2018.
GUFIC BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2018 ,inter alia, to consider and approve the Un-Audited Financial Results of the Company for the quarter ended September 30, 2018. Announcement under Regulation 30 (LODR)-Scheme of Arrangement
Intimation of trading approval obtained from Stock Exchanges for 4,80,000 Equity Shares of Re. 1/- each bearing distinctive nos from 77350001 to 77830000 (both inclusive) issued pursuant to the Scheme of Merger by Absorption of Gufic Stridden Bio-Pharma Private Limited ('Transferor Company') with Gufic Biosciences Limited ('Transferee Company') and its respective shareholders. Outcome of Board Meeting
The Board of Directors of the Company at its Meeting held on October 26, 2018, has considered and approved the following matters : 1. Re-alignment of the KMP in the organization wherein Mrs. Hemal M. Desai would vacate the office from the position of Chief Financial Officer (CFO) w.e.f. the closing of business hours on October 26, 2018. However, Mrs. Desai shall continue to hold the position of Whole Time Director of the Company. As a part... Submission Of Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to the provisions of Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith certificate received from M/s. Gajanan D. Athavale, Practicing Company Secretary, Mumbai for the half year ended September 30, 2018. Kindly take the same on your record. Shareholding for the Period Ended September 30, 2018
Gufic Biosciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click here Compliance - Compliance Certificate For The Half Year Ended September 30, 2018
As per the requirement of Regulation 7 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and electronic share transfer facility are maintained during the period April 01, 2018 to September 30, 2018 (both days inclusive) by the Company's Registrar and Share Transfer Agent, viz., Link Intime India Private Limited, which is registered as Registrar & Share... Compliance - Compliance Certificate For The Half Year Ended September 30, 2018
As per the requirement of Regulation 7 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and electronic share transfer facility are maintained during the period April 01, 2018 to September 30, 2018 (both days inclusive) by the Company's Registrar and Share Transfer Agent, viz., Link Intime India Private Limited, which is registered as Registrar & Share... Announcement under Regulation 30 (LODR)-Allotment
Allotment of shares pursuant to the Scheme of Merger by Absorption of Gufic Stridden Bio-Pharma Private Limited (''Transferor Company'') with Gufic Biosciences Limited (''Transferee Company'') and its respective shareholders